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DiffusionMRI has been successful in identifying the existence of white matter abnormalities in schizophrenia in vivo. However, the role
of these abnormalities in the etiologyof schizophrenia is notwell understood.Accumulating evidence from imaging, histological, genetic,
and immunochemical studies support the involvement of axonal degeneration and neuroinflammation—ubiquitous components of
neurodegenerative disorders—as the underlying pathologies of these abnormalities. Nevertheless, the current imaging modalities can-
not distinguishneuroinflammation fromaxonal degeneration, and thereforeprovide little specificitywith respect to thepathophysiology
progression andwhether it is related to a neurodegenerative process. Free-water imaging is a newmethodology that is sensitive to water
molecules diffusing in the extracellular space. Excessive extracellular volume is a surrogate biomarker for neuroinflammation and canbe
separatedout to reveal abnormalities such as axonal degeneration that affect diffusion characteristics in the tissue.Weapplied free-water
imaging on diffusion MRI data acquired from schizophrenia-diagnosed human subjects with a first psychotic episode. We found a
significant increase in the extracellular volume in both white and graymatter. In contrast, significant signs of axonal degeneration were
limited to focal areas in the frontal lobe whitematter. Our findings demonstrate that neuroinflammation ismore prominent than axonal
degeneration in the early stage of schizophrenia, revealing a pattern shared by many neurodegenerative disorders, in which prolonged
inflammation leads to axonal degeneration. These findings promote anti-inflammatory treatment for early diagnosed schizophrenia
patients.
Introduction
The diffusion MRI methodology of diffusion tensor imaging
(DTI) and its unique ability to detect microstructural changes in
vivo (Basser and Pierpaoli, 1996) provided considerable evidence
for whitematter abnormalities in patients diagnosedwith schizo-
phrenia (Kubicki et al., 2007). Nevertheless, inferring the under-
lying pathophysiology of the white matter abnormalities, or their
relation to the etiology of schizophrenia, is challenging, sinceDTI
indices are sensitive to a large number of possible pathologies
(Assaf and Pasternak, 2008). Two probable pathologies emerge
when considering DTI results in schizophrenia in the context of
histological, genetic, immunochemical, and other imaging find-
ings: (1) axonal degeneration in the form of alteration to the
myelin sheath (Davis et al., 2003; Kubicki et al., 2005; Uranova et
al., 2007) and (2) neuroinflammation (Muller and Schwarz,
2006; Potvin et al., 2008; van Berckel et al., 2008; Doorduin et al.,
2009; Laan et al., 2009). These two pathologies are a hallmark of
neurodegenerative processes (Weiner and Selkoe, 2002), yet dis-
tinguishing between the two is required for the development of
targeted drugs and to understand the etiology and progression of
schizophrenia.
Myelin alterations affect the diffusion anisotropy of water
molecules in the vicinity of axons (Song et al., 2003). In contrast,
neuroinflammation is expected to affect the interstitial extraneu-
ronal space, where microglia and other immunoreactive cells
mediate neuroinflammation (Schwartz et al., 2006), thereby
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increasing isotropically diffusing extracellular water content
(Sykova and Nicholson, 2008). However, despite these micro-
structural differences, the main DTI indices, such as fractional
anisotropy (FA) andmean diffusivity (MD), respond similarly to
the two pathologies with FA decrease and MD increase (Alexan-
der et al., 2007), a common report inmanyDTI studies of schizo-
phrenia patients (Kubicki et al., 2007).
To discriminate between axonal degeneration and neuroin-
flammation in schizophrenia, we applied the previously intro-
duced free-water imaging (Pasternak et al., 2009). The method
explicitly estimates the contribution of freely diffusing water
molecules (Pierpaoli and Jones, 2004; Pasternak et al., 2009),
which is expected to increase with neuroinflammation (Wang et
al., 2011). The free-water contribution can be eliminated, and the
remaining signal provides a measure of diffusion fractional an-
isotropy within tissue (FAT) (Pasternak et al., 2009), which is
more specific to tissue alterations than FA (Metzler-Baddeley et
al., 2011, 2012). We compared a sample of patients within their
first psychotic episode with matched healthy controls to identify
the early pathology of schizophrenia.
Among DTI studies of first-episode patients, many report
widespread white matter abnormalities (Kyriakopoulos and
Frangou, 2009; Peters et al., 2010), in contrast with the typically
more focal findings in other DTI studies (Kubicki et al., 2007)
and, importantly, in histological studies (Uranova et al., 2007) of
chronic patients. If schizophrenia is a neurodegenerative disorder,
the degeneration is expected to showaprogressive anddeteriorating
pattern (Lieberman, 1999; Andreasen, 2010), in contrast with the
current DTI findings. Using free-water imaging, we tested whether
distinguishing the effect of neuroinflammation from that of axonal
degeneration could explain the extent of findings in patients at the
onset of schizophrenia.
Materials andMethods
Subjects.The subjects were 18 patients within their first psychotic episode
and 20matched healthy controls. The first-episode patientswere assessed
during their first hospitalization for psychosis or immediately following
discharge. Included patients had continuous psychotic symptoms or an-
tipsychotic drug treatment for no longer than 1 year and had aDiagnostic
and Statistical Manual of Mental Disorders, fourth edition (DSM-IV),
diagnosis of schizophrenia, schizoaffective disorder, or schizophreni-
formdisorder, based on the Structural Clinical Interview for theDSM-IV
text revision (DSM-IV-TR). The patients were either not medicated
(three patients) or medicated with typical/atypical antipsychotics (Table
1). Thirteen of the patients were also medicated on one or more psychi-
atric medications other than antipsychotics that included anti-
cholinergic drugs (four patients), mood stabilizers (three patients),
antidepressants (six patients), antianxiety medications (three patients),
and -blockers (one patient). Healthy controls were drawn from the
same geographic base as the first-episode group with comparable age,
gender, education, race, and ethnicity (Table 1). No controls met criteria
for any current major DSM-IV-TR Axis I disorders or any history of
psychosis, major depression (recurrent), bipolar disorder, obsessive
compulsive disorder, post-traumatic stress disorder, or developmental
disorders. Controls were also excluded for any history of psychiatric
hospitalizations, prodromal symptoms, schizotypal or other Cluster A
personality disorders, first-degree relatives with psychosis, or any current
or past use of antipsychotics. All subjects met additional exclusion crite-
ria designed to omit neurological comorbidities and substance abuse. All
subjects were recruited as part of the Boston Center for Intervention
Development and Applied Research project. The local institutional re-
view board committee approved all protocols, and all subjects gave in-
formed written consent before participation.
Imaging parameters.MRI scanning was performed at the Brigham and
Women’s Hospital in Boston with a 3 tesla General Electric Signa System
(GE Medical Systems). The MR sequences had high spatial resolution
and included 3D T1-weighted [inversion recovery spoiled gradient re-
called (SPGR)], 3D T2-weighted (CUBE), and diffusion acquisitions.
The IR-SPGR sequence had a repetition time (TR) of 7.8 ms, an echo
time (TE) of 3 ms, an inversion time of 600 ms, a 10° flip angle, a field of
view (FOV) of 256 256mm, a matrix size of 256 256, 176 slices, and
1mm slice thickness. The 3D T2-weighted sequence had a TR of 3 s, a TE
of 90ms, a 90° flip angle, a FOV of 256 256mm, amatrix size of 256
256, 176 slices, and 1 mm slice thickness. The high-resolution diffusion
acquisition was twice refocused and had a TR of 17s, a 90° flip angle, a
FOV of 240 240mm, amatrix size of 144 144, 85 slices, 1.7mm slice
thickness, 51 gradient directions with a b-value of 900 s/mm2, and eight
additional non-diffusion-weighted (b0) images. We used the propriety
GE DTI sequence, which on a 3 tesla GE scanner minimizes TE per each
subject. The mean TE value was 86 ms for both groups (Table 1). Never-
theless, since TE directly affects image quality, we included it as a cova-
riate in the statistical analyses.
Construction of DTI and free-water maps. The diffusion data were cor-
rected for motion and artifacts by means of affine registration with a
reference volume [FLIRT; FMRIB Software Library (FSL), Oxford, UK]
and Rician denoising (Aja-Fernandez et al., 2008). Diffusion gradients
were compensated for rotations. A relative-motion parameter was esti-
mated from the transformation matrices (Ling et al., 2012). The images
were masked to exclude nonbrain areas by manually annotating a label
map that was initialized using Otsu’s method as implemented in the
software 3DSlicer (www.slicer.org). This additional manual step was re-
quired to ensure high-quality cross-subject registration that is not biased
bymasking errors. To account for possible acquisition or filtering biases,
signal-to-noise ratio (SNR) valueswere calculated for the original and for
the filtered b0 images using the formula SNR/, where is themean,
and  is the standard deviation over the repeated b0 images. The SNR
scores were compared across the two groups using a t test and revealed no
significant difference (Table 1).
Maps of FA and MD were calculated for each voxel using 3DSlicer.
Free-water and FAT maps were calculated by fitting the following model in
each voxel (Pasternak et al., 2009): Aq(D, f)  f exp(bq
TDq)  (1 
f)exp(bdwater), where Aq is the modeled attenuated signal (normalized
by the b0) for the applied diffusion gradient q, and b is the b-value. The
first term reflects the tissue compartment, whereD is the diffusion tensor
of this compartment, and f is the fractional volume of the compartment.
The second term reflects an isotropic free-water compartment, with a
fractional volume of 1 f, and dwater is the diffusion coefficient, set to the
diffusivity of water in body temperature (3 103 mm2/s). Of note, in
a typical diffusion MRI acquisition, the free-water diffusivity dictates an
average molecule displacement in the range of a few tens of microns, i.e.,
the signal originates from large enough water pockets, which in the brain
could only appear in the extracellular space. The free-water fractional
volume is therefore proportional to the extracellular volume (Wang et
al., 2011). On the other hand, the signal of the tissue compartment orig-
Table 1. Clinical and experimental parameters
Controls First episode t test
Number of subjects 20 18
Female 5 4
Male 15 14
Age (years) 24.05 3.99 21.61 4.34 t(36)1.88; p 0.07
Education (years) 13.78 2.51 14.17 1.65 t(36) 0.55; p 0.59
Motion (mm) 0.70 0.26 0.68 0.26 t(36)0.22; p 0.83
TE (ms) 85.84 1.36 85.73 1.28 t(36)0.26; p 0.80
SNR (raw) 12.06 1.47 12.12 1.58 t(36) 0.12; p 0.91
SNR filtered 13.05 1.14 13.22 1.18 t(36) 0.46; p 0.65
CPZ (mg/d) 472.24 651.33







The t test column holds the t statistic (with degrees of freedom) and significance value, p, for an unpaired two-
sample t test.
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inates from all other water molecules. These molecules are hindered or
restricted by cellular structures (e.g., membranes and myelin sheaths),
which include all of the intracellular molecules and some extracellular
molecules that are in proximity to cellular restrictions. Fitting tensors to
the tissue compartment therefore provides a better estimate of processes
that occur in the tissue (Metzler-Baddeley et al., 2011), thereby reducing
the effect of partial-volume with the extracellular compartment
(Metzler-Baddeley et al., 2012).
Themodel was fitted using a regularizedminimization process similar
to the algorithmof Pasternak et al. (2009) and updated to use a Euclidean
metric for tensor distances (Pasternak et al., 2010, 2012). The regulariza-
tion incorporates a tensor-based operator (Gur et al., 2009) that is ap-
propriate for both isotropic and anisotropic tensors, applicable for both
gray and white matter. The regularization is essential to stabilize the
model fit, which is ill posed when using conventional single-shell clinical
DTI data acquisition, such as that used here. This regularization ap-
proach was shown to produce comparable results to more advanced
multishell acquisition protocols in which the regularization can be re-
laxed (Pasternak et al., 2012).
The estimation of the free-water fractional volume, and the diffusion
tensor of the tissue compartment, much like the estimation of DTI ten-
sors, can be biased by various variables such as the image resolution,
diffusion protocol parameters, acquisition noise, and the underlying T1
or T2 relaxations (Pasternak et al., 2009). Crossing-fibers may also affect
the estimation of the parameters. However, preliminary results show that
free-water maps generated when accounting for crossing-fibers are sim-
ilar to maps generated using the method described here (Baumgartner et
al., 2012). Therefore, best practice when comparing the free-water de-
rived parameters between groups is to verify that there are no groupwise
differences in the potentially biasing parameters, or to include these as
control variables in the statistical analysis. Following the estimation of
the model, free-water maps were generated by plotting the voxelwise
value of 1 f; FATmapswere generated by calculating the FAof the fitted
tensor, D, in each voxel. These voxels covered the entire masked brain,
including white matter, gray matter, and CSF.
White matter skeleton analysis. The FAmaps of all subjects were united
to build a white matter skeleton, using the Tract Based Spatial Statistics
(TBSS) software (Smith et al., 2006). Individual FA,MD, free-water, and
FAT maps were projected onto the skeleton. A nonparametric
permutations-based test (Nichols and Holmes, 2002) between the first-
episode and control groups was performed on the projected data (Ran-
domize, FSL). Threshold-free cluster enhancement (TFCE) (Smith and
Nichols, 2009) was used to avoid defining arbitrary cluster-forming
thresholds and smoothing levels. The data were tested against an empir-
ical null distribution generated by 5000 permutations for each contrast,
thus providing statistical maps fully corrected for multiple comparisons
across space. A corrected value of p  0.05 was considered significant.
The test was linearly adjusted for motion, age, and TE, which were in-
cluded as covariates. These three covariates are known to affect diffusion
measures and were included to prevent from a systematic bias toward
one of the groups, even though there was not a significant difference in
the average age, motion, and TE between the groups (Table 1). Statistical
maps plotting the corrected p values were visualized using FSL in 2D
(TBSS-fill and FSLview). 3DSlicer was used for volume rendering. Vox-
elwise permutation-based partial correlation tests (Randomize, FSL)
adjusted for age, motion, and TE were performed to establish the
correlation between, on one hand, the free-water or FAT values and, on
the other hand, chlorpromazine (CPZ) equivalent daily dosage value,
duration of medication, Brief Psychiatric Rating Scale (BPRS; a measure
of illness severity) rating (Ventura et al., 2000), or duration of illness. The
significance threshold of the correlation was set to 0.05 corrected for
multiple comparisons.
Brain parcellation analysis. Each anatomical T1 image was masked by
manually annotating a label map created by a brain extraction tool (FSL)
to include the brain and exclude the skull. The masked images were then
automatically segmented into white and gray matter sections using Free-
Surfer (surfer.nmr.mgh.harvard.edu). We compared 70 gray matter sec-
tions (35 in each hemisphere) and 68 white matter sections (34 in each
hemisphere) that were consistently recognized in all the subjects. The
sections weremapped onto the diffusion space by registering themasked
T1 image with themasked T2 image (rigid registration, FLIRT, FSL), and
then registering the T2 image with the masked b0 image (nonlinear reg-
istration, FNIRT, FSL). The mean MD, FAT, and free-water values were
calculated within each section. These values were compared between the
first-episode and control groups via a t test that was performed for each
section separately (Matlab), while adjusting for the age, motion, and TE
covariates. False discovery rate (FDR) correction was applied to account
for multiple comparisons between the different ROIs. Test results that
met the FDR criteria were considered significant. Results that did not
meet the FDR criteria yet had a significance level p 0.05 were consid-
ered trend-level findings. The FDR criteria applies a more strict multiple
comparisons correction than the TFCE-based statistical approach that
was applied on the white matter skeleton. As a result, the FreeSurfer ROI
analysis is likely to have more type II errors (false negatives) than the
TBSS analysis, even though the number of the comparisons is lower for
the ROI analysis. Nevertheless, the FreeSurfer analysis allows the inves-
tigation of gray matter, which is excluded in the TBSS analysis. Further-
more, it avoids between-subject registration issues, which are extremely
inaccurate in cortical areas, and thus provides a more robust way to
compare subject groups than voxel-based ROI analyses.
The FreeSurfer sections were further combined into four global re-
gions of interest (ROIs): right and left hemispherewhitematter, and right
and left hemisphere graymatter. Themean free-water value for each ROI
was calculated as the average over the sections weighted by each section’s
volume (estimated by number of voxels). The mean values of each ROI
were compared between the first-episode and control groups using a t
test (Matlab) while adjusting for the age, motion, and TE covariates.
Clustering together all FreeSurfer ROIs that delineated the ventricles
formed an additional ROI. The mean MD value for this ventricular ROI
was calculated for each subject and compared via a t test.
Results
Abnormalities in diffusion tensor imaging indices on the
white matter skeleton
Analyzing the diffusion data using a conventional DTI model
yielded voxelwisemaps of FAandMDfor each subject. Comparison
of the first-episodegroupwith thecontrol groupwas restricted to the
projection of themaps onto a whitematter skeleton to reduce regis-
tration errors originating from gross volume changes, such as ven-
tricle sizes (Douaud et al., 2007). The first-episode group had
widespreadsignificantly lowerFAvalues than thecontrol group.The
FA abnormalities were distributed globally extending throughmost
brain parts (Fig. 1), covering 30.85% of the left hemisphere white
matter and 30.98% of the right hemisphere white matter. In addi-
tion, the first-episode group showed significantly higherMD values
in areas that spatially overlapped and extended beyond the FA value
changes (Fig. 1), covering 53.61% of the right hemisphere white
matter and 48.78% of the left hemisphere white matter.
Free-water imaging indices abnormalities on the white
matter skeleton
Analyzing the diffusion data with the free-water methodology
yielded an FATmapmeasuring the fractional anisotropy of water
in the tissue and a free-water map that measured the fractional
volume of extracellular water, i.e., molecules that are not re-
stricted by cellular membranes or other cellular microstructures.
The FAT and free-watermapswere projected onto the samewhite
matter skeleton used for the DTI analysis.
The first-episode group showed significantly lower FAT values
comparedwith the control group, in limited brain areas, covering
1.25% of the left hemisphere white matter and 1.65% of the right
hemisphere whitematter (Fig. 2). The affected areas include neu-
ronal connections in the frontal lobe alone, in areas consisting of
parts of the superior longitudinal fasciculus bilaterally; the right
inferior frontal occipital fasciculus; and the intersection of the
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callosal fibers with the right superior corona radiata. Averaging
the FAT values within the areas that showed significant group
differences, and plotting this mean value against age (Fig. 3)
showed that in these brain areas each first-episode subject had
lower FAT values than control individuals in the same age range,
providing a clear separation between the two groups.
Significant increase of free-water values in the first-episode
group showed a global pattern spatially overlapping with theMD
and FA value changes (compare Figs. 1, 2), covering 41.14% of
the left hemisphere white matter and 38.08% of the right hemi-
sphere white matter. There were no voxels with significant corre-
lation between the free-water imaging measures (free-water and
FATmaps) and the following variables: the total BPRS rating, the
duration of illness, the CPZ equivalent daily dosage value, and
duration of medication.
Whole brain analysis
As an alternative to the skeletonized analysis, and to extend the
comparison of the free-water indices into gray matter areas, we
compared the mean free-water values and mean FAT in four
global ROIs (right and left hemisphere white matter, and right
and left hemisphere gray matter) derived from the FreeSurfer
sections. The mean free-water values for the first-episode group
in all of these ROIs were significantly higher than the mean free-
water values of the control group (Fig. 4). The absolute differ-
ences in the means were consistent across these ROIs (Table 2),
with differences in increase of extracellular fractional volume
ranging from 1.1 to 1.6%. Within the control group and within
the first-episode group, there were no significant differences in
the free-water values when comparing the left and right hemi-
sphere in any of the four ROIs.
We further compared the volume of the ROIs (number of
voxels) between the first-episode and control groups, to reveal
any atrophy related group differences. There were no significant
volume differences in the left gray matter (t(33)  0.71; p 
0.48), the right gray matter (t(33)  0.62; p  0.54), the left
white matter (t(33)0.02; p 0.99), or the right white matter
(t(33)0.09; p 0.93) ROIs.
Finally we compared the mean MD values averaged over the
ventricles, as defined by the FreeSurfer ROIs, to identify potential
Figure 1. Abnormal DTI values in first-episode patients. Axial slices (bottom) and 3D rendering (top) demonstrate a global pattern for significant FA value decreases (red to yellow) and for
significant MD value increases (blue to dark blue) throughout the white matter skeleton (green). The FA map is drawn on top of the MDmap and on top of the skeleton.
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biases such as body temperature differences that may have af-
fected the estimation of diffusivity in general. However, there
were no significant differences (t(33)0.99; p 0.33) between
the groups.
Abnormalities of free-water imaging indices in the
gray matter
We looked at each individual gray matter section to see whether
the global changes evinced in white matter are also found in the
gray matter. The free-water value was increased in the vast ma-
jority of the gray matter (64 of 70 gray matter sections) of the
first-episode patients compared with the control group. The in-
crease was significant in 6 of 70 sections (minimal t(33)  3.16;
p  0.0034), with an additional 26 of 70 sections that had a
trend-level group difference (minimal t(33)  2.07; p  0.046).
Similar to the white matter analysis, the free-water increase over-
lapped with a wider extent of MD changes, with 43 of 70 sections
that had a significant MD increase (minimal t(33)  2.30; p 
0.028) and 9 of 70 sections that had a trend-level increase (min-
Figure 2. Abnormal free-water values in first-episode patients. Axial slices (bottom) and 3D rendering (top) demonstrate a localized pattern for significant FAT value decreases (red to yellow) in
fibers that pass through the frontal lobe. A global pattern for significant free-water value increases (blue to dark blue) is found throughout thewhitematter skeleton (green). The FATmap is drawn
on top of the free-water map and on top of the skeleton.
Figure 3. Individual differences in FAT. Each first-episode patient had lower FAT values
than age-matched controls when averaging within the area that showed significant vox-
elwise group differences in FAT. The clear separation between the two groups suggests
that the FAT measure in this area (marked red to yellow in Fig. 2) is a strong biomarker for
schizophrenia.
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imal t(33) 2.03; p 0.05). There were no
atrophy signs of reduced volume in the
gray matter sections, with only a single
section showing a decrease with a trend-
level significance (left pericalcarine cor-
tex; t(33)2.5951; p 0.014).
Contrary to the free-water volume
fraction and MD changes, global changes
in FAT in the graymatterwere not evident.
In 39 of 70 gray matter sections of the
first-episode subjects, the FAT value de-
creased compared to the control group, of
which only a single section had a trend-
level significance level (the left rostral an-
terior cingulate; t(33)2.54; p 0.016).
In the remaining 31 of 70 gray matter sec-
tions, the FAT value increased, yet only in
a single section did this increase have a
trend-level significance level (right mid-
dle temporal cortex; t(33)  2.63; p 
0.013). The mean FAT values in the left
hemisphere graymatter were 0.204 for the
controls and 0.200 for the first-episode
patients (t(33)0.52; p 0.65), and in
the right hemisphere were 0.206 for the
controls and 0.207 for the first-episode
patients (t(33)  0.21; p  0.83). These
values are isotropic, yet slightly higher from FA values, due to the
extraction of the purely isotropic free-water component.
Discussion
Consistent with previous reports, we found widespread white
matter abnormalities in first-episode patients. Using free-water
imaging, we demonstrated for the first time that these abnormal-
ities can be explained by two microstructurally separate compo-
nents: the extracellular volume and the diffusion anisotropy of
water in tissue, FAT. The key finding here is that the majority of
abnormalities in the early stage of schizophrenia are explained by
an increase in the extracellular volume, whereas a decrease in FAT
is limited in its extent to focal areas in the frontal lobe (Fig. 2).
Assuming that neuroinflammation and axonal degeneration are
the two likely white matter pathologies in schizophrenia, our findings
suggest that excessive extracellular volume, reflecting neuroinflamma-
tionandnotdegeneration,isthepredominantpathologyfoundatonset.
Neuroinflammation is a dynamic response of the intrathecal
immune system to harmful stimuli (Streit, 2006). The response is
initiated by the activation of microglia and astrocytes that emit
chemicals that induce excessive osmosis of water from the blood
into the extracellular space (Schwartz et al., 2006). This mecha-
nism is responsible for the increase in the relative volume of the
extracellular space (Sykova and Nicholson, 2008), reflected as an
increase of free-water values, whereas the tissue itself, and hence
the FAT value, remains unchanged. In chronic neuroinflamma-
tion, a secondary effect of cellular damage affects the surrounding
tissue (Streit, 2006). This is believed to play a key role in the
etiology of neurodegenerative disorders, such as multiple sclero-
sis, where an initial lesion induces inflammation that eventually
damages the oligodendrocytes, the myelin sheaths, and, ulti-
mately, the axons and neurons (Weiner and Selkoe, 2002). Such
damage in white matter can be reflected by FAT changes, which is
more specific to tissue changes than the conventional FAmeasure
(Pasternak et al., 2009; Metzler-Baddeley et al., 2012).
The extent of excessive extracellular volume we find in the first-
episode patients suggests that schizophrenia pathophysiology may
show a similar neurodegenerative pattern in which chronic neuro-
inflammation eventually causes axonal degeneration and the related
deterioration in cognitive abilities. This interpretation,which can be
confirmed in longitudinal studies, differs from the current leading
theories of schizophrenia etiology, where neuroinflammation is not
considered a key component. If, indeed, neuroinflammation pre-
cedesdegeneration in thediseaseprogression, thenour findings sug-
gest that the frontal connections, where the decrease of FAT values
was found, are the first fibers to show degeneration. This may be
related to the fact that these fibers are among those still being my-
elinated in late adolescence and early adulthood (Tamnes et al.,
2010), and thus could bemore vulnerable to damage.
The decrease of FAT values in frontal white matter areas corre-
sponds well with the literature findings where pathologies in the
frontal lobe are considered among the hallmarks of schizophrenia
(Cerqueira et al., 2005). In fact, myelin-related abnormalities in
schizophrenia in postmortem studies were foundmostly within the
frontal lobes (Uranova et al., 2007). In addition, a previous meta-
analysis of DTI studies of schizophrenia patients reported that areas
in the left frontal lobe and left temporal lobe consistently show a
decrease of FA values, concluding that there is evidence of localized
myelin deficiencies in schizophrenia (Ellison-Wright and Bullmore,
2009). The FAT value changes we report here further support this
conclusion, as the significant differences between the groups are lo-
calizedaswell.Moreover,whenplotting theFATvaluesoverage (Fig.
Figure4. Global differences in freewater. Free-water values in patients are globally significantly higher than free-water values
in controls. The global pattern of increase is evident both in white and graymatter, in both hemispheres. Black lines represent the
mean and the 95% confidence interval.
Table 2. Global gray andwhitematter ROIs
Mean free water
First episode Controls Difference t(df) ; p
Left gray matter 0.1991 0.1826 0.0165 t(33) 2.48; p 0.0184
Right gray matter 0.2021 0.1885 0.0136 t(33) 2.23; p 0.0331
Left white matter 0.1145 0.1031 0.0115 t(33) 2.54; p 0.0161
Right white matter 0.1154 0.1042 0.0112 t(33) 2.55; p 0.0155
t(df) is the t statistic and degrees of freedom; p is the significance value.
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3), a remarkable separation between the groups appears, which sug-
gests that FAT is a strongbiomarker for schizophrenia.However, the
free-water value differences we report here offer an important addi-
tion to the localized theory, asserting that there is a global extracel-
lular process (both inwhite and graymatter) that occurs at the same
time, and possibly precedes local axonal alterations.
A global pattern of white matter abnormalities was noticed in
many recent DTI studies of first-episode patients (Kyriakopoulos
and Frangou, 2009; Peters et al., 2010), possibly also due to steadily
improving imaging and analysis tools (Kubicki and Shenton, 2009).
However, it was theorized previously that the pattern reflects a ge-
netic abnormality in the protein pathways controlling myelination,
leading to wide-extent myelin alterations (Konrad and Winterer,
2008), not addressing the findings in the chronic stages that usually
reveal focal degeneration patterns instead (Ellison-Wright and Bull-
more, 2009). Sincehereweareable todistinguish thecontributionof
axonal alterations from extracellular changes, we can assert that the
global component evinced in the first-episodepatients is of an extra-
cellular source, which fits well with the expected effect of neuroin-
flammation but not with the expected effect of myelin alterations.
Finding histological evidence of neuroinflammation is highly
complicated by the fact that this process is dynamic andmay not be
prevalent in chronic cases (Connor et al., 2011). However, neuroin-
flammation traces have been reported in subjects who committed
suicide during a psychotic event (Steiner et al., 2008). Previous im-
aging studies demonstrated the involvement of neuroinflammation
in schizophrenia as higher binding rates to [11C](R)-PK11195 (van
Berckel et al., 2008), indicating higher rates of activated microglia
than in controls. This requires PET scanning, which is expensive,
invasive, and has poorer spatial resolution compared to diffusion
MRI. Of importance, the diffusionMRI advantages enable longitu-
dinal studies.Neuroinflammationwas indirectly suggestedby imag-
ing measures such as increased T2 relaxation (Pfefferbaum et al.,
1999),magnetization transfer ratio (Peters et al., 2010), and changes
inMD(DeLisi et al., 2006;Garver et al., 2008). The sensitivity ofDTI
measurements to neuroinflammation has been demonstrated in
other neurodegenerative diseases,where inflammation is often a key
component in the etiology (Weiner and Selkoe, 2002; Cloak et al.,
2004; Acosta-Cabronero et al., 2010). In line with these findings,
here we report an overlap between free-water value and MD value
abnormalities. However, we also show that MD and noncorrected
FA values are highly spatially correlated, and thus do not allow sep-
arationbetweenneuroinflammation anddegeneration that the free-
water and FAT values provide.
Other pathologies that could explain an increase in the extracel-
lular volume were detected previously in schizophrenia, however
neverwith a global pattern. These include cellularmembrane break-
down, abnormally low cell density, and low dendritic number and
volume (Selemon et al., 2002, 2003; Segal et al., 2009). Theremay be
a global reduction in perineuronal extracellular matrix; however, so
far this has only been reported in medial temporal structures (Pan-
tazopoulos et al., 2010). There may be inflated Virchow–Robin
spaces, which can accumulate water pockets in the periventricular
space (Wuerfel et al., 2008), yet there are no explicit reports for such
findings in schizophrenia. Atrophy is also frequently reported in
schizophrenia imaging studies; however, it was not evident in our
data. This could be explained by the progressive nature of atrophy
(e.g.,Whitford et al., 2006), whichmay not yet bemanifested in our
first-episode cohort.
Age, gender, and motion differences are additional possible
confounds that theoretically could explain systematic increase in
the diffusivity for the schizophrenia group. In our data there were
no significant differences in age and gender distribution, nor
were there significant differences in SNR or motion observed
between the two groups (Table 1). Moreover, age and motion
parameters were added as control variables in the statistical anal-
ysis. Increased T2 relaxation could also bias the estimation; how-
ever, overestimation of the free-water volume could be either due
to an increased extracellular relative volume, or due to an in-
crease in the T2 relaxation of the extracellular pool. Both options
imply changes in the extracellular space that are likely related to
inflammation. Therefore, based on currently available evidence,
neuroinflammation appears the most likely explanation for the
excessive extracellular volume.
The source of neuroinflammation in schizophrenia and inmany
other neurodegenerative disorders is still under debate. Neuroin-
flammation could be the result of an infectious disease or an auto-
immune response (Streit et al., 2004). It could also be a response of
the immune system to a chronic state of mental stress (Muller and
Schwarz, 2006)ora response tomedication, althoughherewedonot
find a correlation between an increase in free-water values and the
dosage or duration of antipsychotic medications. The effect of non-
psychotic or nonprescription drugs remains a possible confound.
However, many of the psychiatric drugs have an anti-inflammatory
effect (Sommer et al., 2012),whichmight explainwhy inflammation
is less prevalent in chronic cases.
Early detection of inflammation in schizophrenia is therefore an
important task in revealing the etiology, especially since neuroin-
flammation could be reversed with interventions, such as immuno-
suppressive drugs, which are likely to be more efficient in the early
stage of the disease. Our results here suggest that the free-water con-
trast showspromise as anearly stageneuroinflammatorybiomarker,
which might provide a time window for anti-inflammatory treat-
ment to minimize the possible cascade of neurodegenerative pro-
cesses, potentially minimizing the associated symptoms. The
proposed analysis provides a foundation for future longitudinal
studies that further investigate theassociationbetweenneuroinflam-
mation anddegeneration, as demonstratedby theprogressionof the
free-water and the FAT parameters. This kind of longitudinal analy-
sis would be important to further understand the etiology of schizo-
phrenia as well as other neurodegenerative disorders.
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